Ebola Vaccine Approved by FDA
Ervebo has been approved for the prevention of Ebola virus disease, caused by Zaire ebolavirus in individuals 18 years of age and older.
Up to 43% of Antibiotic Prescriptions in the United States May Be Inappropriate
Investigators assessing how frequently antibiotics are prescribed without a documented indication discovered that 18% of antibiotic prescriptions had no documented indication in a nationally representative sample of ambulatory clinic encounters.
Rabies Vaccine Modified to Target B Cells Is Faster, Stronger
Incorporating a signaling protein known as B cell activating factor into the rabies vaccine improved speed and strength of the antibody responses, investigators at Thomas Jefferson University found.
Patients With Asthma Can Benefit from Getting the Flu Vaccine
Asthma patients benefited from flu vaccines, according to a study that examined 6 influenza virus seasons.
Crowdsourced Materials Used to Promote Hepatitis Testing Among MSM in China
While results of a study on crowdsourced materials promoting hepatitis testing were complicated by intervention sharing, 20% of MSM reported first time testing.
Incidence of Vaccine-Preventable Diseases Shapes Legislation
A new study examines the association between vaccine-preventable disease incidence and state vaccine exemption legislation.
Are Patients Responsible for Initiating Conversations About PrEP?
After analyzing electronic medical records from 161 patients across 90 VHA sites, investigators determined that patients initiated 94% of conversations about PrEP.
TAK-003 Dengue Vaccine Shows Promise in Phase 3 Trial in Children and Adolescents
The vaccine candidate, TAK-003, is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all 4 serotypes.
Modified Vaccinia Ankara Vaccine Efficacious For Smallpox Protection in Phase 3 Study
Modified vaccinia Ankara vaccination showed efficacy protecting against smallpox in a phase 3 clinical trial, with fewer adverse events reported compared to the ACAM2000 vaccine group.
Importance of Empathy in HIV Treatment
Timothy Ray Brown, formerly known as the “Berlin Patient” explains why it is important for providers to form relationships with patients and avoid stigma and judgment.
Predictive Model Discerns Patients at Risk for CRE
A prediction model using prior health care exposure information could discern patients likely to harbor carbapenem-resistant Enterobacteriaceae at time of hospital admission.
Improving Care for Criminalized Populations at Risk for HIV in Botswana
Several key populations with heightened risk for HIV face criminalization in Botswana. The Botswana Family Welfare Association targeted efforts to improve care for these key populations.
Survey Reveals Beliefs About Transgender Clients Among Nursing Students
An educational research study reveals positive attitudes and a willingness to provide care among pre-licensure Bachelor of Science nursing students.
Exploring the Experiences of Young Adults with Perinatally Acquired HIV
A new study examined young adults with perinatally acquired HIV living in South Florida in order to shed light on their lived experiences.
"Don't Call Me the Berlin Patient, Call Me Timothy Ray Brown"
“My story is important only because it proves that HIV can be cured. And if something has happened, once in medical science, it can happen again,” Brown told Contagion®.
PrEP "Purview Paradox" Leaves Providers Uncertain
Neither infectious disease specialists nor primary care providers appear to consider PrEP care to fall within their practice, and similar debates have taken place between nurses and physicians.
NYC Health + Hospitals Celebrates 5 Years of Special Pathogens Preparedness
Since 2014 NYC Health + Hospitals has worked to maintain preparedness against diseases like Ebola.
FDA Approves Fluzone High-Dose Quadrivalent Influenza Vaccine for Older Adults
Fluzone High-Dose Quadrivalent is given to people 65 years of age and older to help prevent influenza disease caused by influenza A and B strains contained in the vaccine.
Neuraminidase Protein Could be a Target for New Influenza Treatments and Vaccines
While most influenza vaccines target the binding protein hemagglutinin, a new study shows cross-strain results for treatment and prevention focused on the glycoprotein neuraminidase.
Gaps in Pediatric Vaccination Linked With Uninsured Status
An analysis of vaccination data among children born in 2015 and 2016 found high and stable coverage, but highlighted sociodemographic disparities in coverage.
Lower Prevalence of Oral HPV Among Vaccinated Female Adolescents
A study of female adolescents at a health clinic in New York City has found the presence of HPV in the oral cavity is not uncommon, but the results also offer support for vaccination.
WHO Report Indicates Progress, Highlights Gaps Toward TB Elimination
According to the WHO’s latest Global TB Report, more than 7 million individuals received treatment for the disease in 2018, but funding gaps could stall progress toward ending TB by 2030.
What Can the United States Learn from Australia's 2019 Flu Season?
H3N2, a particularly virulent strain of influenza, blew through Australia. Is it coming to the United States this fall and winter?
The Relationship Between PTSD and Infectious Diseases
A new study points to an increased risk for infections in patients with PTSD.
State of Play in Lyme Disease Vaccine Research: Public Health Watch
A group provides an overview of ongoing research and current approaches being evaluated for the prevention of tick-borne disease.
CDC Report Details Vaccine Coverage for 2018-19 School Year
Kindergarten vaccination coverage is near the recommended 95%, but nonexempt holdouts, which could be addressed, can still lead to outbreaks.
Diluted Ebola Vaccine Effective in Animal Model Study
Scientists from the National Institutes of Health are hopeful that diluting a dose of the VSV vaccine could be efficacious and stretch vaccine supplies even further.
HIV Prevention Strategies Beyond PrEP, Catalyzing Clinic Improvement
Gregory Felzien, MD, AAHIVS, discusses prevention beyond PrEP and creating a safe environment for patients with HIV.
Promising Steps Toward a Universal Influenza Vaccine
Using a unique approach of targeting the stalk of the hemagglutinin, investigators are taking steps toward developing a universal influenza vaccine candidate.
HIV Prevention Strategies in Rural Communities
Gregory Felzien, MD, AAHIVS, discusses barriers to HIV care, particularly in neglected rural areas.
2 Clarke Drive Cranbury, NJ 08512